Literature DB >> 683207

Oral contraceptives and birth defects.

K J Rothman, C Louik.   

Abstract

We reviewed the birth certificates and hospital records of 7723 infants those mothers had reported using oral contraceptives. The overall frequency of malformation was 4.3 per cent for infants whose mothers terminated use of oral contraceptives shortly before conception, as compared with 3.3 per cent for infants whose mothers did not take oral conceptives diring the three years before conception. The 90 per cent confidence limits for the prevalence ratio were 1.0 and 1.7. No difference was apparent for major malformations. For specific malformations the most notable difference was for undescented testis, but this excess, like the overall excess, could be explained by sampling variability. Despite the slightly greater rate of minor malformations in the short-interval group, a reasonable interpretation of these data would be that oral contraceptives present no major teratogenic hazard.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 683207     DOI: 10.1056/NEJM197809072991006

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  10 in total

Review 1.  Prenatal adverse effects of various drugs and chemicals. A review of substances of frequent concern to mothers in the community.

Authors:  M Bologa-Campeanu; G Koren; M Rieder; M McGuigan
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Jul-Aug

2.  Maternal use of oral contraceptives and risk of hypospadias - a population-based case-control study.

Authors:  Pia Wogelius; Erzsébet Horváth-Puhó; Lars Pedersen; Mette Nørgaard; Andrew E Czeizel; Henrik Toft Sørensen
Journal:  Eur J Epidemiol       Date:  2006-11-01       Impact factor: 8.082

3.  Maternal drug histories and congenital malformations: limb reduction defects and oral clefts.

Authors:  L Hill; M Murphy; M McDowall; A H Paul
Journal:  J Epidemiol Community Health       Date:  1988-03       Impact factor: 3.710

4.  Effect of prenatal exposure to hydroxyprogesterone on steroidogenic enzymes in male rats.

Authors:  T Pushpalatha; P Ramachandra Reddy; P Sreenivasula Reddy
Journal:  Naturwissenschaften       Date:  2002-12-20

5.  A case-control study of the aetiology of cryptorchidism.

Authors:  A J Swerdlow; K H Wood; P G Smith
Journal:  J Epidemiol Community Health       Date:  1983-09       Impact factor: 3.710

Review 6.  Testicular dysgenesis syndrome and the estrogen hypothesis: a quantitative meta-analysis.

Authors:  Olwenn V Martin; Tassos Shialis; John N Lester; Mark D Scrimshaw; Alan R Boobis; Nikolaos Voulvoulis
Journal:  Environ Health Perspect       Date:  2008-02       Impact factor: 9.031

7.  Descriptive epidemiology of testicular and prostatic cancer in Los Angeles.

Authors:  R K Ross; J W McCurtis; B E Henderson; H R Menck; T M Mack; S P Martin
Journal:  Br J Cancer       Date:  1979-03       Impact factor: 7.640

8.  Risk factors for congenital cryptorchidism in a prospective birth cohort study.

Authors:  Ida N Damgaard; Tina K Jensen; Jørgen H Petersen; Niels E Skakkebaek; Jorma Toppari; Katharina M Main
Journal:  PLoS One       Date:  2008-08-25       Impact factor: 3.240

9.  Risk assessment of growth hormones and antimicrobial residues in meat.

Authors:  Sang-Hee Jeong; Daejin Kang; Myung-Woon Lim; Chang Soo Kang; Ha Jung Sung
Journal:  Toxicol Res       Date:  2010-12

10.  Maternal use of oral contraceptives and risk of birth defects in Denmark: prospective, nationwide cohort study.

Authors:  Brittany M Charlton; Ditte Mølgaard-Nielsen; Henrik Svanström; Jan Wohlfahrt; Björn Pasternak; Mads Melbye
Journal:  BMJ       Date:  2016-01-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.